IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL

Journal of Surgical Oncology

Volumn 111, Issue 8, 2015, Pages 969-974

  Fang, Yujiang ^a,b   Chen, Xuhui ^a,c   Bai, Qian ^b   Qin, Chenglu ^b,c   Mohamud, Abdimalik O ^b   Zhu, Ziwen ^b   Ball, Tyler W ^b   Ruth, Caleb M ^b   Newcomer, Dylan R ^b   Herrick, Elizabeth J ^b   Nicholl, Michael B ^b  

^a Des Moines University College of Osteopathic Medicine   (United States)

^b University of Missouri   (United States)

^c Luohu Hospital   (China)

Author keywords

apoptosis; IL 9; melanoma cells; proliferation

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GROWTH INHIBITOR; INTERLEUKIN 9; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; HUMAN; MELANOMA; METABOLISM; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-9; MELANOMA; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 84934435293     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23930     Document Type: Article

References (36)

1. Khan N, Khan MK, Almasan A, et al,: The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys 2011; 80: 645.
2. Siegel R, Ma J, Zou Z, et al,: Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9.
3. Nicholl MB, Elashoff D, Takeuchi H, et al,: Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients. Ann Surg 2011; 253: 116.
4. Kalaaji AN,: Cytokine therapy in advanced melanoma. J Drugs Dermatol 2007; 6: 374.
5. Goswami R, Kaplan MH,: A brief history of IL-9. J Immunol 2011; 186: 3283.
6. Lu Y, Hong S, Li H,: Th9 cells promote antitumor immune responses in vivo. J Clin Invest 2013; 122: 4160.
7. Longphre M, Li D, Gallup M, et al,: Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin. Invest 1999; 104: 1375.
8. Louahed J, Toda M, Jen J, et al,: Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000; 22: 649.
9. Reader JR, Hyde DM, Schelegle ES, et al,: Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol 2003; 28: 664.
10. Vermeer PD, Harson R, Einwalter LA, et al,: Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J Respir Cell Mol Biol 2003; 28: 286.
11. Gounni AS, Hamid Q, Rahman SM, et al,: IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J Immunol 2004; 173: 2771.
12. Purwar R, Schlapbach C, Xiao S, et al,: Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 2012; 18: 1248.
13. Fang Y, DeMarco VG, Nicholl MB,: Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 2012; 103: 1090.
14. Fang Y, Herrick EJ, Nicholl MB,: A possible role for perforin and granzyme B in resveratrol enhanced radiosensitivity of prostate cancer. J Androl 2012; 33: 752.
15. Fang Y, Bradley MJ, Cook KM, et al,: A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res 2013; 183: 645.
16. Fang Y, Bradley MJ, Bai Q, et al,: Hydrogen peroxide enhances radiation-induced apoptosis and inhibition of melanoma cell proliferation. Anticancer Res. 2013; 33: 1799.
17. Fang Y, Sharp GC, Braley-Mullen H,: Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 2008; 172: 1591.
18. Fang Y, Yu S, Braley-Mullen H,: TGF-β promotes proliferation of thyroid epithelial cells in IFN-γ-/- mice by downregulation of p21 and p27 via AKT pathway. Am J Pathol 2012; 180: 650.
19. Fang Y, Wei Y, DeMarco V, et al,: Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 2007; 171: 875.
20. Fang Y, Sharp GC, Yagita H, et al,: A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J Pathol 2008; 216: 505.
21. Johnson DG, Walker CL,: Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999; 39: 295.
22. Sherr CJ,: G1 phaseprogression: Cycling on cue. Cell 1994; 79: 551.
23. Ohtsubo M, Theodoras AM, Schumacher J, et al,: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995; 15: 2612.
24. Sherr CJ,: D-Type cyclins. Trends Biochem Sci 1995; 20: 187.
25. Thompson CB,: Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456.
26. Zhang H, Xu Q, Krajewski S, et al,: BAR: An apoptosis regulator at the intersection of caspases and BCL2 family proteins. Proc Natl Acad Sci USA 2000; 97: 2597.
27. Griffith TS, Brunner T, Fletcher SM, et al,: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
28. Fang Y, Braley-Mullen H,: Cultured murine thyroid epithelial cells expressing transgenic Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein are protected from Fas-mediated apoptosis. Endocrinology 2008; 149: 1121.
29. Baraldo S, Faffe DS, Moore PE, et al,: Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 284: L1093.
30. Yamasaki A, Saleh A, Koussih L, et al,: IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS ONE 2010; 5: e9178.
31. Chen TC, Hinton DR, Apuzzo ML, et al,: Differential effects of tumor necrosis factor-alpha on proliferation, cell surface antigen expression, and cytokine interactions in malignant gliomas. Neurosurgery 1993; 32: 85.
32. Nicholl MB, Ledgewood CL, Chen X, et al,: IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor. Cytokine 2014; 70: 126.
33. Gomez Sarosi LA, Rieber MS, Rieber M,: Hydrogen peroxide increases a 55-kDa tyrosinase concomitantly with induction of p53-dependent p21/waf1 expression and a greater Bax/Bcl-2 ratio in pigmented melanoma. Biochem Biophys Res Commun 2003; 312: 355.
34. Sah NK, Khan Z, Khan GJ, et al,: Structural, functional and therapeutic biology of survivin. Cancer Lett 2006; 244: 164.
35. Yamamoto H, Ngan CY, Monden M,: Cancer cells survive with survivin. Cancer Sci 2008; 99: 1709.
36. Altieri DC,: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8: 61.